Biventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination
Eur Heart J Cardiovasc Imaging
.
2022 Jan 24;23(2):e87.
doi: 10.1093/ehjci/jeab206.
Authors
Hisataka Maki
1
,
Tadao Aikawa
2
3
,
Tatsuro Ibe
1
,
Noriko Oyama-Manabe
2
,
Hideo Fujita
1
Affiliations
1
Department of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama 330-8503, Japan.
2
Department of Radiology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama 330-8503, Japan.
3
Department of Cardiology, Hokkaido Cardiovascular Hospital, 1-30, Minami-27, Nishi-13, Chuo-ku, Sapporo 064-8622, Japan.
PMID:
34601566
DOI:
10.1093/ehjci/jeab206
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
2019-nCoV Vaccine mRNA-1273
COVID-19*
Humans
Myocarditis*
SARS-CoV-2
Vaccination
Substances
2019-nCoV Vaccine mRNA-1273
Grants and funding
19K17189 to T.A/JSPS KAKENHI
Fukuda Foundation for Medical Technology (to T.A.)
Akiyama Life Science Foundation (to T.A.)
Grants-in-Aid for Regional R&D Proposal-Based Program from Northern Advancement Center for Science & Technology of Hokkaido Japan (to T.A.)
19K17189/JSPS KAKENHI
Fukuda Foundation for Medical Technology
Akiyama Life Science Foundation
Grants-in-Aid for Regional R&D Proposal-Based Program
Northern Advancement Center for Science & Technology of Hokkaido Japan